Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Myriad Genetics Inc (MYGN)

Myriad Genetics Inc (MYGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
MYGN
Myriad Genetics’s Q1 Earnings Call: Our Top 5 Analyst Questions StockStory - Tue May 12, 12:35AM CDT

Myriad Genetics’s Q1 Earnings Call: Our Top 5 Analyst Questions

MYGN : 4.07 (-3.33%)
DLTR
3 of Wall Street’s Favorite Stocks with Open Questions StockStory - Mon May 11, 11:38PM CDT

3 of Wall Street’s Favorite Stocks with Open Questions

AR : 36.33 (-0.71%)
DLTR : 89.05 (-1.08%)
MYGN : 4.07 (-3.33%)
Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences GlobeNewswire - Thu May 7, 3:05PM CDT

SALT LAKE CITY, May 07, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc . (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced Myriad management will participate...

MYGN : 4.07 (-3.33%)
MYGN
MYGN Q1 Deep Dive: Hereditary Cancer Strength, Launch Investments Pressure Margins StockStory - Wed May 6, 10:40AM CDT

MYGN Q1 Deep Dive: Hereditary Cancer Strength, Launch Investments Pressure Margins

MYGN : 4.07 (-3.33%)
Myriad: Q1 Earnings Snapshot AP - Tue May 5, 4:14PM CDT

Myriad: Q1 Earnings Snapshot

MYGN : 4.07 (-3.33%)
MYGN
Myriad Genetics (NASDAQ:MYGN) Misses Q1 CY2026 Sales Expectations, Stock Drops 16.2% StockStory - Tue May 5, 3:16PM CDT

Myriad Genetics (NASDAQ:MYGN) Misses Q1 CY2026 Sales Expectations, Stock Drops 16.2%

MYGN : 4.07 (-3.33%)
Myriad Genetics Reports First Quarter 2026 Financial Results; Reiterates 2026 Financial Guidance Reflecting Ongoing Progress in the Cancer Care Continuum Business GlobeNewswire - Tue May 5, 3:05PM CDT

Highl ights First quarter 2026 revenue of $200.4 million grew 2% year-over-year, reflecting stable test volume and 2% year-over-year growth in average revenue per test. First quarter...

MYGN : 4.07 (-3.33%)
Myriad Genetics Reports Tomorrow on Whether New Product Launches Gained Commercial Traction or Merely Potential Barchart - Mon May 4, 4:21PM CDT

Barchart Research What to Expect from MYGN Earnings MYGN Generated May 4, 2026 Current Price $4.94 EPS Estimate $$-0.16 Consensus Rating Hold Average Move 18.41% Myriad Genetics Reports Tomorrow on Whether...

MYGN : 4.07 (-3.33%)
MYGN
Myriad Genetics (MYGN) To Report Earnings Tomorrow: Here Is What To Expect StockStory - Sun May 3, 10:13PM CDT

Myriad Genetics (MYGN) To Report Earnings Tomorrow: Here Is What To Expect

MYGN : 4.07 (-3.33%)
Myriad Genetics National Survey: 88% of Patients with Depression and/or Anxiety Would Feel More Confident with a Personalized Mental Health Care Plan GlobeNewswire - Thu Apr 30, 8:05AM CDT

SALT LAKE CITY, April 30, 2026 (GLOBE NEWSWIRE) -- The latest GeneSight ® Mental Health Monitor, a nationwide survey from Myriad Genetics, Inc. , (NASDAQ: MYGN), a leader in molecular diagnostic...

MYGN : 4.07 (-3.33%)

Barchart Exclusives

Inflation Has Pushed this Dividend Aristocrat to 52-Week Lows. Why It’s Still Not Quite Time to Buy. Barchart - Tue May 12, 6:30PM CDT
McDonald's stock is trading near its 52-week lows and has a dividend yield of aroudn 2.7%. However, the stock does not look like a compelling buy yet. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.